UBS Maintains a 'Buy' on Calix (CALX); Raising Price Target On OCNW Accretion
Tweet Send to a Friend
UBS maintains a 'Buy' on Calix (NYSE: CALX), raises PT from $14.50 to $20.
UBS analyst says, "We continue ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
UBS analyst says, "We continue ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
